2024/12/06 19:30:15 | |
---|---|
Price | |
258.45 EUR | |
Difference | -0.67% (-1.75) |
ISIN | US0311621009 |
Symbol | AMGN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 138,418 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 258.15 EUR |
High | 259.45 EUR |
Low | 258.05 EUR |
Close (prev. day) | 260.20 EUR |
VWAP | 142.19 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/11/26 | Global Equity Ratings | ||
2024/11/19 | Global Equity Ratings | ||
2024/11/05 | Global Equity Ratings | ||
2024/10/29 | Global Equity Ratings | ||
2024/10/22 | Global Equity Ratings |
2024/12/06 19:30:15 | |
---|---|
Price | |
258.45 EUR | |
Difference | -0.67% (-1.75) |
ISIN | US0311621009 |
Symbol | AMGN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 138,418 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 258.15 EUR |
High | 259.45 EUR |
Low | 258.05 EUR |
Close (prev. day) | 260.20 EUR |
VWAP | 142.19 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -8.14% | +3.21% | +39.51% |
Perf (abs.) | -22.90 | +8.05 | +73.19 |
Beta | 0.62 | 0.67 | 0.43 |
Volatility | 26.81 | 27.16 | 23.97 |
Ø price 5 days | Ø volume 5 days (pcs.) | 262.34 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 279.51 EUR (4) |
Ø price 100 days | Ø volume 100 days (pcs.) | 291.07 EUR (5) |
Ø price 250 days | Ø volume 250 days (pcs.) | 279.94 EUR (5) |
YTD High | date | 318.05 EUR (2024/07/25) |
YTD Low | date | 245.25 EUR (2024/04/19) |
52 Weeks High | date | 318.05 EUR (2024/07/25) |
52 Weeks Low | date | 245.25 EUR (2024/04/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/12/06 | 17:35 | 258.05 EUR | 0.15 | 33 |
Vienna Stock Exchange | 2024/12/06 | 17:32 | 258.50 EUR | 0.00 | 9 |
Tradegate | 2024/12/06 | 22:26 | 258.10 EUR | 0.73 | 83 |
Stuttgart | 2024/12/06 | 21:33 | 257.25 EUR | 0.14 | 8 |
SIX Swiss Exchange | 2022/11/14 | 17:36 | 180.00 CHF | 0.00 | 1 |
SIX Swiss Exchange | - | - | - | 0.00 | - |
Nasdaq | 2024/12/06 | 22:00 | 272.58 USD | 1,083.19 | 55,329 |
Munich | 2024/12/06 | 08:05 | 259.60 EUR | 0.00 | 3 |
Hong Kong Stock Exchange | 2024/11/19 | 02:15 | 1,850.00 HKD | - | - |
Hanover | 2024/12/06 | 17:25 | 258.35 EUR | 0.00 | 4 |
Hamburg | 2024/12/06 | 17:25 | 258.35 EUR | 0.00 | 3 |
Frankfurt | 2024/12/06 | 17:20 | 258.50 EUR | 0.02 | 4 |
Euronext Milan MTF Trading After Hours | 2024/12/04 | 18:21 | 271.30 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/12/06 | 17:44 | 258.30 EUR | 0.00 | 1 |
Duesseldorf | 2024/12/06 | 19:30 | 258.45 EUR | 0.00 | 7 |
Berlin | 2024/12/06 | 08:08 | 258.45 EUR | 0.00 | 2 |
AMGEN INC. |
- - |
One Amgen Center Drive - 91320-1799 Thousand Oaks |
Telefon: +1-805-447-1000 |
Fax: +1-805-447-1010 |
E-mail: - |
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. |
Brian Druker | Member of Board of Directors |
Mary Klotman | Member of Board of Directors |
Michael Drake | Member of Board of Directors |
Omar Ishrak | Member of Board of Directors |
Tyler Jacks | Member of Board of Directors |
Wanda Austin | Member of Board of Directors |
Amy Miles | Member of Board of Directors |
Charles Holley | Member of Board of Directors |
Ellen Kullman | Member of Board of Directors |
Greg Garland | Member of Board of Directors |
Robert Eckert | Member of Board of Directors |
Robert A. Bradway | Chairman of Managing Board |
David M. Reese | Member of Executive Committee |
Jackie Elbonne | Member of Executive Committee |
James Bradner | Member of Executive Committee |
Jonathan Graham | Member of Executive Committee |
Mike Zahigan | Member of Executive Committee |
Murdo Gordon | Member of Executive Committee |
Paul Burton | Member of Executive Committee |
Peter Griffith | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer